#CureIPF
https://www.imperial.ac.uk/mtw-centre-fibrosing-lung-disease/
Editor-In-Chief BMJ Open Respiratory Research
Just out in ERJ and led by Dr. Na'ama Avitzur
A 🧵👇
(key take-away 👉 sex matters to patients with PF and their disease impacts this)
#OpenAccess #CurePF #CureIPF
publications.ersnet.org/content/erj/...
Interesting story.
1) Brexit actually increased migration.
2) Students r source of UKs immigration‘problem’, likely due to our outstanding universities
3) Cumulative asylum seeker retention builds up
4) A ‘hostile environment’ might work but at what cost & for what impact? 😬
Interesting story.
1) Brexit actually increased migration.
2) Students r source of UKs immigration‘problem’, likely due to our outstanding universities
3) Cumulative asylum seeker retention builds up
4) A ‘hostile environment’ might work but at what cost & for what impact? 😬
Alcaraz vs Sinner?
Tottenham vs Arsenal?
Giants vs Dodgers?
Nemesis vs motivation?
Alcaraz vs Sinner?
Tottenham vs Arsenal?
Giants vs Dodgers?
Nemesis vs motivation?
The current system is breaking if not already broken.
Incentivises research fraud.
Will prevent people seeing the wood because of all the dodgy trees.
#LessIsMore
Limit individuals to publishing a MAXIMUM of 10 articles/year
🌟 Quality > quantity
🌟 Forced to choose valuable work to which they have meaningfully contributed
🌟 Requires change in academic metrics
@benpatrickwill.bsky.social
@ipfdoc.bsky.social
The current system is breaking if not already broken.
Incentivises research fraud.
Will prevent people seeing the wood because of all the dodgy trees.
#LessIsMore
Along with Nerandomilast this shows importance of cAMP/PDE4 pathways in fibrosis & opens door 4 other therapies targeting these pathways!
#FutureLooksBright #CureIPF
Positive trial 🗞️
Change in FVC at 52 weeks difference of 95.6mL (!), and 2* endpoints like K-BILD
@ipfdoc.bsky.social @kaminskimed.bsky.social @tkulkarni.bsky.social @jskim8223.bsky.social
www.theglobeandmail.com/investing/ma...
Along with Nerandomilast this shows importance of cAMP/PDE4 pathways in fibrosis & opens door 4 other therapies targeting these pathways!
#FutureLooksBright #CureIPF
Positive trial 🗞️
Change in FVC at 52 weeks difference of 95.6mL (!), and 2* endpoints like K-BILD
@ipfdoc.bsky.social @kaminskimed.bsky.social @tkulkarni.bsky.social @jskim8223.bsky.social
www.theglobeandmail.com/investing/ma...
Positive trial 🗞️
Change in FVC at 52 weeks difference of 95.6mL (!), and 2* endpoints like K-BILD
@ipfdoc.bsky.social @kaminskimed.bsky.social @tkulkarni.bsky.social @jskim8223.bsky.social
www.theglobeandmail.com/investing/ma...
This is about men exploiting and committing sexual violence against women and girls
THIS is the issue to bring to the forefront address
This is about men exploiting and committing sexual violence against women and girls
THIS is the issue to bring to the forefront address
www.nature.com/articles/d41...
@natcomms.nature.com @alirezamnk.bsky.social
@spmic-uon.bsky.social @ipfdoc.bsky.social
www.nature.com/articles/s41...
www.nature.com/articles/d41...
@natcomms.nature.com @alirezamnk.bsky.social
@spmic-uon.bsky.social @ipfdoc.bsky.social
www.nature.com/articles/s41...
This one explores the looming peer review crisis. As many of you know, it's becoming significantly more difficult for journal editors to find scholars willing to serve as peer reviewers for submitted manuscripts.
This one explores the looming peer review crisis. As many of you know, it's becoming significantly more difficult for journal editors to find scholars willing to serve as peer reviewers for submitted manuscripts.
Derived, tested case definitions performed well, created a dataset of ILD. Incidence was stable, prevalence increased, mortality decreased for ILD & IPF sub-group
@kerrijohannson.bsky.social
@agrantorser.bsky.social
tinyurl.com/5n7x5w2h
Derived, tested case definitions performed well, created a dataset of ILD. Incidence was stable, prevalence increased, mortality decreased for ILD & IPF sub-group
@kerrijohannson.bsky.social
@agrantorser.bsky.social
tinyurl.com/5n7x5w2h
@atscommunity.bsky.social #medsky
Have a listen: outoftheblue.transistor.fm
@atscommunity.bsky.social #medsky
Have a listen: outoftheblue.transistor.fm
Thanks for sharing @kerrijohannson.bsky.social @bmj.com
Only review for journals you know
Do not submit to predatory journals
Do NOT contribute to this crap
Stop thinking about 'getting papers' and think about 'advancing your field' - this needs to change for promotion and merit
www.theguardian.com/science/2025...
Thanks for sharing @kerrijohannson.bsky.social @bmj.com
Only review for journals you know
Do not submit to predatory journals
Do NOT contribute to this crap
Stop thinking about 'getting papers' and think about 'advancing your field' - this needs to change for promotion and merit
www.theguardian.com/science/2025...
Only review for journals you know
Do not submit to predatory journals
Do NOT contribute to this crap
Stop thinking about 'getting papers' and think about 'advancing your field' - this needs to change for promotion and merit
www.theguardian.com/science/2025...
#AnswersOnAPostcard
#AnswersOnAPostcard
There maybe further positive moves in future #SmallSteps. #GettingThere 🙏🙏
There maybe further positive moves in future #SmallSteps. #GettingThere 🙏🙏
The burden of ILD is higher than thought AND rising.
Burden in rural communities higher than cities! 🤔?🌾🚜🐤
Mortality 📉 suggests Dx and Mx improving 🥳
Kudos to @kerrijohannson.bsky.social & team!
www.atsjournals.org/doi/suppl/10...
🧵👇
📣 TL:DR Incidence stable, prevalence rising, improved survival for ILD & IPF over 10 years.
Numbers much higher than prior reports for ILD & IPF.
The burden of ILD is higher than thought AND rising.
Burden in rural communities higher than cities! 🤔?🌾🚜🐤
Mortality 📉 suggests Dx and Mx improving 🥳
Kudos to @kerrijohannson.bsky.social & team!
A population based study of trends in incidence, prevalence, mortality of ILD over 10 yrs.
Good news: Mortality ⬇️.
Expected news: Incidence unchanged, Prevalence ⬆️
Important News: there are a lot of ILD patients
👏🏼 Drs Johannson, Fisher & team!!!
www.atsjournals.org/doi/full/10....
A population based study of trends in incidence, prevalence, mortality of ILD over 10 yrs.
Good news: Mortality ⬇️.
Expected news: Incidence unchanged, Prevalence ⬆️
Important News: there are a lot of ILD patients
👏🏼 Drs Johannson, Fisher & team!!!
www.atsjournals.org/doi/full/10....
www.atsjournals.org/doi/suppl/10...
🧵👇
📣 TL:DR Incidence stable, prevalence rising, improved survival for ILD & IPF over 10 years.
Numbers much higher than prior reports for ILD & IPF.
www.atsjournals.org/doi/suppl/10...
🧵👇
📣 TL:DR Incidence stable, prevalence rising, improved survival for ILD & IPF over 10 years.
Numbers much higher than prior reports for ILD & IPF.